title: Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus.
abstract: BACKGROUND
  High admission blood glucose levels after acute myocardial infarction (AMI) are common and associated with an increased risk of death in subjects with and without known diabetes. Recent data indicate a high prevalence of abnormal glucose metabolism in patients with unknown diabetes at the time of AMI. We investigated the predictive value of admission blood glucose levels after AMI for long-term prognosis in patients with and without previously diagnosed diabetes mellitus, particularly in those with unknown diabetes but with blood glucose levels in the diabetic range.
  
  
  METHODS
  In a retrospective study with prospective follow-up, 846 patients (737 without and 109 with known diabetes) were eligible for follow-up during a median of 50 months (range, 0-93 months).
  
  
  RESULTS
  During follow-up, 208 nondiabetic patients (28.2%) and 47 diabetic patients (43.1%) died (P =.002). An increase of 18 mg/dL (1 mmol/L) in glucose level was associated with a 4% increase of mortality risk in nondiabetic patients and 5% in diabetic patients (both P<.05). Of the 737 previously nondiabetic subjects, 101 had admission blood glucose levels of 200 mg/dL (11.1 mmol/L) or more, and mortality in these patients was comparable to that in patients who had established diabetes (42.6% vs 43.1%).
  
  
  CONCLUSIONS
  Admission blood glucose level after AMI is an independent predictor of long-term mortality in patients with and without known diabetes. Subjects with unknown diabetes and admission glucose levels of 200 mg/dL (11.1 mmol/L) or more after AMI have mortality rates comparable to those of subjects with established diabetes. Admission blood glucose level may serve to identify subjects at high long-term mortality risk, in particular among those with unknown diabetes.
authors.affiliation: Department of Cardiology, VU University Medical Center, Amsterdam, the Netherlands.
authors.forename: Ischa
authors.initials: I
authors.lastname: Stranders
authors.forename: Michaela
authors.initials: M
authors.lastname: Diamant
authors.forename: Rogier E
authors.initials: RE
authors.lastname: van Gelder
authors.forename: Hugo J
authors.initials: HJ
authors.lastname: Spruijt
authors.forename: Jos W R
authors.initials: JW
authors.lastname: Twisk
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Heine
authors.forename: Frans C
authors.initials: FC
authors.lastname: Visser
mesh_terms: D000368:Aged; D001786:Blood Glucose / Q000032:analysis*; D003925:Diabetic Angiopathies / Q000097:blood* / Q000401:mortality*; D005260:Female; D006760:Hospitalization; D006801:Humans; D006943:Hyperglycemia / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000401:mortality*; D012189:Retrospective Studies; D018570:Risk Assessment
chemical_list: D001786:Blood Glucose